CLU and breast angiosarcoma: Clusterin is a multifunctional protein with guises that include chaperone, lipoprotein (ApoJ), and negative regulator of the terminal complement pathway [27]; higher levels of clusterin in BA males predict tighter control of the terminal pathway, a prediction supported by finding no difference in TCC between groups.